A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new ...

The following is a summary of “Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection ...

Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

The press release highlights the poor prognosis for patients with heart failure with preserved ejection fraction (HFpEF), indicating a significant unmet medical need which could suggest challenges ...

Faun1083 has demonstrated positive in-vivo efficacy in multiple preclinical animal models, including rat sugen hypoxia and ...

This could eventually lead to therapies to prevent heart failure in humans,” said Jeroen ... heart regeneration in zebrafish but not in mice suggesting that Hmga1 plays a key role in heart ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...